E-LIB Suche - Ergebnisse für: Marignier, R

1

P.010 Safety and efficacy of inebilizumab in AQP4+ NMOSD pa..:

Paul, F ; Marignier, R ; Lindsey, JW...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S17-S17 , 2024

Link: https://doi.org/10.1017/..

2

Frequency and clinical relevance of MOG-antibodies in CSF i..:

Galati, G. ; Pique, J. ; Horellou, P....
European Journal of Paediatric Neurology. 51 (2024) - p. 79-83 , 2024

Link: https://doi.org/10.1016/..

3

Association of cytokine proteins with disease activity in N..:

Aktas, O. ; Pittock, S.J. ; Kim, H.J....
Clinical Neurophysiology. 159 (2024) - p. e19 , 2024

Link: https://doi.org/10.1016/..

4

P.009 Long-term comparative efficacy of inebilizumab from N..:

Cree, B ; Suero, B ; Walsh, S...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S16-S17 , 2024

Link: https://doi.org/10.1017/..

5

Intramedullary abscess secondary to infective endocarditis ..:

Theuriet, J. ; Richard, C. ; Cotton, F...
Revue Neurologique. 178 (2022) 7 - p. 745-746 , 2022

Link: https://doi.org/10.1016/..

6

Acute and subacute myelopathy:

Marignier, R.
Revue Neurologique. 177 (2021) 5 - p. 557-566 , 2021

Link: https://doi.org/10.1016/..

7

MRI characteristics of MOG-Ab associated disease in adults:..:

Shor, N. ; Deschamps, R. ; Cobo Calvo, A....
Revue Neurologique. 177 (2021) 1-2 - p. 39-50 , 2021

Link: https://doi.org/10.1016/..

8

Clinical failure of natalizumab in multiple sclerosis: Spec..:

Guery, D. ; Marignier, R. ; Durand-Dubief, F....
Revue Neurologique. 177 (2021) 10 - p. 1241-1249 , 2021

Link: https://doi.org/10.1016/..

9

A comparative evaluation of different neuromyelitis optica ..:

Papeix, C. ; Beigneux, Y. ; Maillart, E....
European Journal of Neurology. 27 (2020) 11 - p. 2250-2256 , 2020

Link: https://doi.org/10.1111/..

10

Long-term Efficacy and Safety of Inebilizumab for Neuromyel..:

Cree, B.A.C ; Bennett, J. L. ; Kim, H. J....
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

11

Serum Neurofilament Light Chain Levels (sNfL) Correlate Bes..:

Atkas, O. ; Hartung, H-P. ; Smith, M.A....
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

12

Myelin oligodendrocyte glycoprotein antibody-associated opt..:

Cescutti, M. ; Davenas, C. ; Tilikete, C....
Revue Neurologique. 176 (2020) 7-8 - p. 626-627 , 2020

Link: https://doi.org/10.1016/..

13

Clinical, imaging and follow‐up study of optic neuritis ass..:

Shor, N. ; Aboab, J. ; Maillart, E....
European Journal of Neurology. 27 (2019) 2 - p. 384-391 , 2019

Link: https://doi.org/10.1111/..

14

Myelin oligodendrocyte glycoprotein antibody associated dis..:

Cobo‐Calvo, A. ; Ruiz, A. ; Marignier, R.
European Journal of Neurology. 26 (2019) 5 - p. , 2019

Link: https://doi.org/10.1111/..

15

"Myelitis migrans": A rare cause of treatable myelitis:

Jaulent, P. ; Pegat, A. ; Grosset-Janin, C....
Revue Neurologique. 174 (2018) 10 - p. 745-747 , 2018

Link: https://doi.org/10.1016/..